Amitiza Constipation

Links shared publicly online about this topic

AmitizaTM (lubiprostone) May Help Improve Symptoms Of Irritable Bowel Syndrome With Constipation

medicalnewstoday.com — “A new study found that amitiza™ (lubiprostone) may help relieve the symptoms associated with constipation-predominant irritable bowel syndrome (ibs-c). ibs is a condition that affects nearlyView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on May 20, 2009 at 10:28 pm By:

Sucampo Receives Marketing Authorization For Amitiza(R) In Switzerland For Treatment Of Chronic Idiopathic Constipation

medicalnewstoday.com — “Sucampo Pharma Europe Ltd., a subsidiary of Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP), announced that Swissmedic, the Swiss Agency for Therapeutic Products, has granted a marketing authorizatiView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on November 21, 2009 at 9:24 am By:

Health_Feed Health Feed Health News

Sucampo Receives Marketing Authorization For Amitiza(R) In Switzerland For Treatment Of Chronic Idiopathic Constipa... http://ow.ly/163l4F

3 years ago...

Novartis Inks Deal To Speed Up Vaccine Production - Forbes.com

forbes.com — “Pact with Synthetic Genomics Vaccines is for three years.View full resource at forbes.com

  • View Related
  • Share

Most Recently Shared on October 7, 2010 at 8:14 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Novartis Inks Deal To Speed Up Vaccine Production: Pact with Synthetic Genomics Vaccines is for three years. http://bit.ly/cgKPhY #drug

2 years ago...

Sucampo announces completion of lubiprostone phase 3 trial for CIC in Japanese patients

news-medical.net — “Sucampo Pharmaceuticals, Inc. announced that phase 3 double blind trial of lubiprostone (marketed as AMITIZA (R) in the U.S.) for chronic idiopathic constipation in Japanese patients has been completed.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on June 10, 2010 at 10:28 am By:

NewsMedical News-Medical.Net Health News

Sucampo announces completion of lubiprostone phase 3 trial for CIC in Japanese patients: Sucampo Pharmaceuticals, ... http://bit.ly/cZStGn

2 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Related WisdomCards

Related Health Centers

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390